Marion Lanier - Concepedia

Author

Marion Lanier

Neurocrine Biosciences (United States)ORCID

Also Known As

Lanier, M.C., M. LANIER, M. Lanier, Marion C. Lanier, Marion Lanier

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Neurocrine Biosciences (United States)Almirall (Spain)Human BioMolecular Research Institute Sanford Burnham Prebys Medical Discovery Institute Lehigh University

About

Marion Lanier is an author at Neurocrine Biosciences (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	607
2	Natural Sciences	9	9	268
3	Engineering	2	2	152
4	Health Sciences	2	2	154
5	Public Health	1	1	22

Marion Lanier

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Small-Molecule Inhibitors of the Wnt Pathway Potently Promote Cardiomyocytes From Human Embryonic Stem Cell–Derived Mesoderm Erik Willems, Sean Spiering, Herman Davidovics, Circulation Research	2011	243
Small Molecule-Mediated TGF-β Type II Receptor Degradation Promotes Cardiomyogenesis in Embryonic Stem Cells Erik Willems, Joaquim Cabral-Teixeira, Dennis Schade, Cell stem cell Cardiac MuscleCardiomyopathySignal TransductionDevelopmental BiologyMedicine	2012	136
Molecular Umbrellas Václav Janout, Marion Lanier, Steven L. Regen Journal of the American Chemical Society Chemical EngineeringEngineeringPhysicochemical AnalysisSurface ChemistryAltmetric Attention Score	1996	82
Sterol−Polyamine Conjugates as Synthetic Ionophores Manette Merritt, Marion Lanier, Gang Deng, Journal of the American Chemical Society Lipid PreparationBioorganic ChemistryDerivativesBiochemistryEngineering	1998	70
Synthesis and SAR of <i>b</i>-Annulated 1,4-Dihydropyridines Define Cardiomyogenic Compounds as Novel Inhibitors of TGFβ Signaling Dennis Schade, Marion Lanier, Erik Willems, Journal of Medicinal Chemistry	2012	66
Wnt Inhibition Correlates with Human Embryonic Stem Cell Cardiomyogenesis: A Structure–Activity Relationship Study Based on Inhibitors for the Wnt Response Marion Lanier, Dennis Schade, Erik Willems, Journal of Medicinal Chemistry Cardiac MuscleCardiac RegenerationCardiovascular Translational ResearchMolecular PharmacologySignaling Pathway	2011	65
Design and Synthesis of Molecular Umbrellas Václav Janout, Marion Lanier, Steven L. Regen Journal of the American Chemical Society	1997	61
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists Joshua Wollam, Michelle Solomon, Christiane Villescaz, Journal of Allergy and Clinical Immunology	2024	48
2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub>Receptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents Deborah H. Slee, Yongsheng Chen, Xiaohu Zhang, Journal of Medicinal Chemistry	2008	43
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure Marion Lanier, Jason Pickens, Simone V. Bigi, ACS Medicinal Chemistry Letters Heart FailureCardiovascular PharmacologyCell DeathPharmacotherapyCardiovascular Toxicity	2017	43

Page 1